Related Experiment Video
Updated: Aug 11, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse
C W Hooker1, W B Lott, D Harrich
1HIV-1 and Hepatitis C Units, Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital, Herston, St. Lucia, Queensland, Australia.
Abstract:
Early HIV-1 reverse transcription can be separated into initiation and elongation phases. Here we show, using PCR analysis of negative-strand strong-stop DNA [(-)ssDNA] synthesis in intact virus, that different reverse transcriptase (RT) inhibitors affect distinct phases of early natural endogenous reverse transcription (NERT). The effects of nevirapine on NERT were consistent with a mechanism of action including both specific and nonspecific binding events. The nonspecific component of this inhibition targeted the elongation reaction, whereas the specific effect seemed principally to be directed at very early events (initiation or the initiation-elongation switch). In contrast, foscarnet and the nucleoside analog ddATP inhibited both early and late (-)ssDNA synthesis in a similar manner. We also examined compounds that targeted other viral proteins and found that Ro24-7429 (a Tat antagonist) and rosmarinic acid (an integrase inhibitor) also directly inhibited RT. Our results indicate that NERT can be used to identify and evaluate compounds that directly target the reverse transcription complex.
Insights
This study reveals how different HIV-1 reverse transcriptase inhibitors impact early viral DNA synthesis. Natural endogenous reverse transcription (NERT) can identify compounds targeting this crucial viral process.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Early HIV-1 reverse transcription involves distinct initiation and elongation phases.
- Understanding these phases is crucial for developing effective antiviral therapies.
Purpose of the Study:
- To investigate how different reverse transcriptase (RT) inhibitors affect the distinct phases of early natural endogenous reverse transcription (NERT).
- To evaluate the utility of NERT for identifying and characterizing novel RT inhibitors.
Main Methods:
- Utilized PCR analysis to study negative-strand strong-stop DNA [(-)ssDNA] synthesis in intact HIV-1.
- Assessed the effects of various compounds, including nevirapine, foscarnet, ddATP, Ro24-7429, and rosmarinic acid, on NERT.
Main Results:
- Different RT inhibitors demonstrated distinct effects on NERT phases.
- Nevirapine exhibited both specific and nonspecific inhibition, affecting initiation and elongation.
- Foscarnet and ddATP inhibited both early and late (-)ssDNA synthesis similarly.
- Tat antagonist Ro24-7429 and integrase inhibitor rosmarinic acid also directly inhibited RT.
Conclusions:
- NERT is a valuable method for dissecting the mechanisms of RT inhibitors.
- The NERT assay can effectively identify and evaluate compounds that directly target the HIV-1 reverse transcription complex.
More Related Videos
13:07Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells
Published on: January 30, 2019
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Retrovirus Life Cycles
Viruses with RNA Genomes
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly